Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,121 to 2,140 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders. | Int J Mol Sci | 2022 | 35682599 | PubTator, text mining | PubMed |
| Remodeling of the m6A RNA landscape in the conversion of acute lymphoblastic leukemia cells to macrophages. | Leukemia | 2022 | 35681051 | PubTator, text mining | PubMed |
| An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas. | Front Genet | 2022 | 35677557 | PubTator, text mining | PubMed |
| Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. | BMC Cancer | 2022 | 35676619 | PubTator, text mining | PubMed |
| IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression. | Cell Death Discov | 2022 | 35676262 | PubTator, text mining | PubMed |
| [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia]. | Nan Fang Yi Ke Da Xue Xue Bao | 2022 | 35673912 | PubTator, text mining | PubMed |
| Structural basis for MTA1c-mediated DNA N6-adenine methylation. | Nat Commun | 2022 | 35672411 | PubTator, text mining | PubMed |
| Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer. | Pharmgenomics Pers Med | 2022 | 35669943 | PubTator, text mining | PubMed |
| Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | 35669909 | PubTator, text mining | PubMed |
| Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35669515 | PubTator, text mining | PubMed |
| 3D-Printed β-Tricalcium Phosphate Scaffolds Promote Osteogenic Differentiation of Bone Marrow-Deprived Mesenchymal Stem Cells in an N6-methyladenosine-Dependent Manner. | Int J Bioprint | 2022 | 35669331 | PubTator, text mining | PubMed |
| N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients. | J Oncol | 2022 | 35669241 | PubTator, text mining | PubMed |
| PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine. | Dev Cell | 2022 | 35659339 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression. | Contrast Media Mol Imaging | 2022 | 35655723 | PubTator, text mining | PubMed |
| m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients. | Front Public Health | 2022 | 35655464 | PubTator, text mining | PubMed |
| circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA. | J Exp Clin Cancer Res | 2022 | 35650605 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. | Nat Commun | 2022 | 35650238 | PubTator, text mining | PubMed |
| Detailed resume of RNA m6A demethylases. | Acta Pharm Sin B | 2022 | 35646549 | PubTator, text mining | PubMed |
| Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer. | Front Genet | 2022 | 35646057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=107